Ironwood Pharmaceuticals (IRWD) Other Non Operating Income (2011 - 2026)
Ironwood Pharmaceuticals (IRWD) posted Other Non Operating Income of $42000.0 for Q1 2026, down 45.45% sequentially from $77000.0 in Q4 2025, and up 13.51% YoY from $37000.0 in Q1 2025.
Ironwood Pharmaceuticals (IRWD) Other Non Operating Income (2011 - 2026) Analysis & Trends
Ironwood Pharmaceuticals has reported Other Non Operating Income for 12 years, with the latest figure at $42000.0 in Q1 2026.
- Quarterly Other Non Operating Income rose 13.51% year-over-year to $42000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $198000.0 (up 435.14% YoY) and the FY2025 annual result came in at $193000.0, down 69.84% from the prior year.
- Other Non Operating Income declined to $42000.0 in Q1 2026 per IRWD's latest filing, from $77000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $730000.0 in Q1 2022 and troughed at -$681000.0 in Q2 2022.
- A 4-year average of $50600.0 and a median of $41000.0 in 2025 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2022 and 2023: Other Non Operating Income surged 103.77% in 2022, then tumbled 97.4% in 2023.
- Over 4 years, Other Non Operating Income stood at $52000.0 in 2022, then tumbled by 63.46% to $19000.0 in 2023, then surged by 305.26% to $77000.0 in 2025, then sank by 45.45% to $42000.0 in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $42000.0, $77000.0, and $40000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Ironwood Pharmaceuticals | 688.03 Mn | 608.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 42,000.00 |
| Mar 31, 2026 | 42,000.00 |
| Dec 31, 2025 | 77,000.00 |
| Sep 30, 2025 | 40,000.00 |
| Jun 30, 2025 | 39,000.00 |
| Mar 31, 2025 | 37,000.00 |
| Mar 31, 2023 | 19,000.00 |
| Dec 31, 2022 | 52,000.00 |
| Sep 30, 2022 | 151,000.00 |
| Jun 30, 2022 | -681,000.00 |
| Mar 31, 2022 | 730,000.00 |
| Dec 31, 2021 | -1.38 Mn |
| Sep 30, 2021 | 2.16 Mn |
| Jun 30, 2021 | -3.17 Mn |
| Mar 31, 2021 | 2.39 Mn |
| Dec 31, 2020 | -6.16 Mn |
| Sep 30, 2020 | -2.62 Mn |
| Jun 30, 2020 | -467,000.00 |
| Mar 31, 2020 | 27,000.00 |
| Dec 31, 2019 | 34.00 Mn |